Summary
Since plasma kallikrein activates human neutrophils, and in plasma prekallikrein (PK) circulates complexed with high molecular weight kininogen (HK), we determined whether HK could mediate kallikrein’s association with neutrophils. Human neutrophils were found to possess surface-membrane binding sites for HK but no internalization was detected at 37°C. 125I-HK binding to neutrophils was dependent upon Zn++, specific, saturable and reversible with a Kd of 9–18 nM and 40,000–70,000 sites per cell. Furthermore, HK found in neutrophils (240 ng/107 neutrophils) also served as a cofactor for HNE secretion since neutrophils deficient in HK have reduced HNE secretion when stimulated in plasma deficient in HK or with purified kallikrein. Thus, neutrophil surface HK may serve as a receptor for kallikrein. Fibrinogen inhibited 125I-fibrinogen bound specifically and reversibly to human neutrophils. Zn++ (50 µM) was required for binding of 125I-fibrinogen to neutrophils and the addition of Ca++ (2 mM) increased the binding 2-fold. Excess HK completely inhibited binding of and displaced labeled fibringogen as well as unlabeled fibrinogen. Binding of125I-fibrinogen was saturable with an apparent Kd of 170 nM and 140,000 sites/neutrophil. The binding of 125I-fibrinogen to neutrophils was not inhibited by the peptide RGDS derived from the α-chain of fibrinogen, nor by the monoclonal antibodies (MAB) 10E5 to the platelet glycoprotein IIb/IIIa heterodimer. Fibrinogen binding was inhibited by a γ-chain peptide CYGHHLGGAKQAGDV and by MAB OKM1 but was not inhibited by OKM10, a MAB to a different domain of the adhesion glycoprotein Mac-1 (CR3). HK binding to neutrophils was not inhibited by OKM1. These observations were consistent with a further finding that fibrinogen is a noncompetitive inhibitor of 1251-HK binding to neutrophils. These studies indicate that fibrinogen specifically binds to an integrin receptor (Mac-1) on the neutrophil surface through the carboxy terminal of the γ-chain and that HK inhibits this interaction.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Abbreviations
- HK:
-
high molecular weight kininogen
- HNE:
-
human neutrophil elastase
- FNDP:
-
fibronectin degradation products
- MAB:
-
monoclonal antibody
- GP:
-
glycoprotein
- CR3 :
-
complement receptor type 3
- PK:
-
prekallikrein
- ELISA:
-
enzyme-linked immunosorbent assay
References
M. Silverberg, J. E. Nicoll, and A. P. Kaplan. The mechanism by which the light chain of cleaved HMW-kininogen augments the activation of prekallikrein, factor XI and Hageman factor. Thromb. Res. 20:173–189, (1980).
R. E. Thompson, Jr. R. Mandle, and A. P. Kaplan. Studies of binding of prekallikrein and factor XI to high molecular weight kininogen and its light chain. Proc. Natl. Acad. Sci. USA 76:4862–4866, (1979).
A. P. Kaplan, A. B. Kay, and K. F. Austen. A prealbumin activator of prekallikrein. III. Appearance of chemotactic activity for human neutrophils. J. Exp. Med. 135:81–97, (1972).
M. Schapira, E. Despland, C. F. Scott, L. A. Boxer, and R. W. Colman. Purified human plasma kallikrein aggregates human blood neutrophils. J. Clin Invest. 69:1199–1201, (1972).
Y. T. Wachtfogel, U. Kucich, H. L. James, C. F. Scott, M. Schapira, M. Zimmerman, A. B. Cohen, and R. W. Colman. Human plasma kallikrein releases neutrophil elastase during blood coagulation. J. Clin. Invest. 72:1672–1677, (1983).
L. Vroman, A. L Adams, G. C. Fischer, and P. C. Munoz. Interaction of high molecular weight kininogen, factor XII and fibrinogen in plasma at interfaces. Blood 55:156–159, (1980).
A. H. Schmaier, L. Silver, A. L. Adams, G. C. Fischer, P. C. Mounoz, L. Vroman, and R. W. Colman. The effect of high molecular weight kininogen on surface-adsorbed fibrinogen. Thromb. Res. 33:51–67, (1984).
A. H. Schmaier, A. Zuckerberg, C. Silverman, J. Kuchibhotla, G. P. Tuszynski, and R. W. Colman High molecular weight kininogen. A secreted platelet protein. J. Clin. Invest. 71:1477–1489, (1983).
D. M. Kerbiriou-Nabias, F. O. Garcia, and M.-J. Larrieu. Radioimmunoassays of human high and low molecular weight kininogens in plasma and platelets. Brit. J. Haem. 56:273–286, (1984).
P. J. Fraker and Jr. S. C. Speck. Protein and cell membrane iodinations with a sparingly soluble chloroamide 1,3,4,6-tetrachloro-3 alpha, 6 alpha-diphenylglycoluril. Biochem. Biophys. Res. Commun. 80:849–857, (1978).
E. J. Gustafson, D. Schutsky, L. C. Knight, and A. H. Schmaier. High molecular weight kininogen binds to unstimulated platelets. J. Clin. Invest. 78:310–318, (1986).
R. J. Baugh and J. Travis. Human leukocyte granule elastase: rapid isolation and characterization. Biochemistry 15:836–841, (1976).
B. S. Coller, E. I. Peerschke, L. E. Scudder, and C. A. Sullivan. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa. J. Clin. Invest. 72:325–338, (1983).
R. F. Todd III, J. A. Roach, and M. A. Arnaout. The modulated expression of M05, a human myelomonocytic plasma membrane antigen. Blood 65:964–973, (1985).
R. W. Colman, A. Bagdasarian, R. C. Talamo, C. F. Scott, M. Sevy, J. A. Guimares, J. V. Pierce, and A. P. Kaplan. Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman-dependent pathways. J. Clin. Invest. 56:1650–1662, (1975).
M. J. Castillo, K. Nakajima, M. Zimmerman, and J. C. Powers. Sensitive substrates for human leukocyte and porcine pancreatic elastase. A study of the merits of various chromophoric and fluorogenic leaving groups in assays for serine proteases. Anal. Biochem. 99:53–64, (1979).
Y. T. Wachtfogel, R. A. Pixley, U. Kucich, W. Abrams, G. Weinbaum, M. Schapira, and R. W. Colman. Purified plasma factor XIIa aggregates human neutrophils and causes degranulation. Blood 67:1731–1737, (1986).
R. Mueller. Determination of affinity and specificity of anti-Hapten antibodies by competitive radioimmunoassay. Methods Enzymol. 92:589–601, (1983).
A. J. Schmaier, D. Schutsky, A. Farber, L. D. Silver, H. N. Bradford, and R. W. Colman Determination of the bifunctional properties of high molecular weight kininogen by studies with monoclonal antibodies directed to each of its chains. J. Biol. Chem., 262:1405–1411, (1987).
P. F. Canellas and A. E. Karu. Statistical package for analysis of competitive ELISA results. J. Immunol. Methods 47:375–385, (1981).
P. J. Munson and D. Rodbard. LIGAND: A versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107:220–239, (1980).
L. F. Brass and S. J. Shattil. Changes in surface-bound and exchangable calcium during platelet activation. J. Biol. Chem. 257:14000–14005, (1982).
R. Pytela, M. D. Pierschbacher, M. H. Ginsberg, E. F. Plow, and E. Ruoslahti. Platelet membrane glycoprotein IIb/IIIa: member of a family of Arg-Gly-Asp-Aspspecific adhesion receptors. Science 231:1559–1562, (1986).
M. Kloczewiak, S. Timmons, T. J. Lukas, and J. Hawiger. Platelet receptor recognition site of human fibrinogen synthesis and structure-function relationship of peptides corresponding to the carboxyterminal segment of gamma chain. Biochemistry 23:1767–1774, (1984).
R. M. Senior, W. F. Skogen, G. L. Griffin, and G. D. Wilner. Effects of fibrinogen derivatives upon the inflammatory response. J. Clin. Invest. 77:1014–1019, (1986).
I. Hayashi, H. Kato, S. Iwanaga, and S. Oh-ishi. Rat plasma high molecular weight kininogen. J. Biol. Chem. 260:6115–6123, (1985).
T. Shimada, H. Kato, and S. Iwanaga. Effect of metal ions on the surface mediated activation of factor XII and prekallikrein. In: Kinins ‘84. L. Greenberg, ed. Conference at Savannah, GA (abstract), (1984).
C. F. Scott, L. D. Silver, M. Schapiro, and R. W. Colman. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor. J. Clin. Invest. 73:954–962, (1984).
Jr. R. Mandle, R. W. Colman, and A. P. Kaplan. Identification of prekallikrein and high molecular weight kininogen as a complex in human plasma. Proc. Natl. Acad. Sci. USA 73:4179–4183, (1976).
R. W. Colman, Y. Wachtfogel, U. Kucich, G. Weinbaum, S. Hahn, R. A. Pixley, C. F. Scott, de A. Agostini, D. Burger, and M. Schapira. Effect of cleavage of the heavy chain of human plasma kallikrein on its functional properties. Blood 65:311–318, (1985).
F. Van der Graaf, G. Tans, B. N. Bouma, and J. H. Griffin. Isolation and functional properties of the heavy and light chains of human plasma kallikrein. J. Biol. Chem. 257:14300–14305, (1982).
G. A. Marguerie, E. F. Plow, and T. S. Edgington. Human platelets possess an inducible and saturable receptor specific for fibrinogen. J. Biol. Chem. 254:5357–5363, (1979).
J. N. Lindon, G. McManama, L. Kushner, E. W. Merrill, and E. W. Salzman. Does the confirmation of adsorbed fibrinogen dictate platelet interactions with artificial surfaces? Blood 68:355–362, (1986).
M. F. Scully and V. V. Kakkar. Structural features of fibrinogen associated with binding to chelated c zinc. Biochem. Biophys. Acta 700:130–133, (1982).
C. R. Zobel. The platelet cytoskeleton: evidence for its structure from interactions with ZnC12. J. Submicrosc. Cytol. Pathol. 20:268–275, (1988).
E. Ruoslahti and M. D. Pierschbacher. New perspectives in cell adhesion: RGD and integrins. Science 238:491–497, (1987).
R. W. Watt, B. A. Cottrell, D. D. Strong, and R. F. Doolittle Amino acid sequence studies on the a chain of human fibrinogen. Overlapping sequences providing the complete sequence. Biochemistry 18:5410–5422, (1979).
T. K. Gartner and J. S. Bennett. The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet agga and fibrinogen binding to activated platelet. J. Biol. Chem. 260:11891–11896, (1985).
Y. T. Wachtfogel, W. Abrams, U. Kucich, G. Weinbaum, M. Schapira, and R. W. Colman. Fibronectin degradation products containing the cytoadhesive tetrapeptide stimulate human neutrophil degranulation. J. Clin. Invest. 81:1310–1316, (1988).
J. I. Weitz, S. L. Landman, K. A. Crowly, S. Birken, and F. J. Morgan. Development of an assay for in vivo human neutrophil elastase activity. J. Clin. Invest. 78:155–162, (1986).
N. Dana, B. Styrt, J. Griffin, R. F. Todd III, M. Klempher, and M. A. Arnaout. Two functional domains in the phagocyte membrane. Glycoprotein MoI identified by monoclonal antibodies. J. Immunology 137:3259–3263, (1986).
M. A. Arnaout, N. Dana, J. Pitt, and R. F. Todd III. Deficiency of two human leukocyte surface membrane glycoproteins (MoI and LFA-1). Fed. Proc. 44:2664–2670, (1985).
D. C. Altieri, T. Edgington, and P. M. Mannucci. Oligospecificity of cellular adhesion receptor Mac-1 encompasses an inducable recognition specificity for fibrinogen. J. Cell Biol. 107:1893–1900, (1988).
D. C. Altieri, R. Bader, and P. M. Mannucci. Structural diversity among cellular adhesion receptors: fibrinogen binding is a novel biological property of the monocyte differentiation antigen OKM1. Thromb. Hemost. 58:1052, (1987).
R. O. Hynes. Integrins: A family of cell surface receptors. Cell 48:549–554, (1987).
E. F. Plow, J. C. Loftus, E. G. Levin, D. S. Lou, D. Dixon, J. Forsyth, and M. H. Ginsberg. Immunologic relationship between platelet membrane glycoprotein llb/IIIa and cell surface molecules expressed by a variety of cells. Proc. Natl. Acad. Sci. USA 83:6002–6006, (1986).
F. Sanchez-Madrid, J. A. Nagy, E. Robbins, P. Simm, and T. A. Springer. A human leukocyte differentiation antigen family with distinct alpha subunits and a common beta subunit: the lymphocyte-function associated antigen (LFA-1), the C3bi complement receptor (OKM1/Mac-1), and the p150,95 molecule. J. Exp. Med. 158:1785–1803, (1983).
T. A. Springer, L. J. Miller, and D. C. Anderson. p150,95,the third member of the Mac-1, LFA-1 human leukocyte adhesion glycoprotein family. J. Immunol. 136: 240, (1986).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer Science+Business Media New York
About this chapter
Cite this chapter
Colman, R.W. (1990). Interactions between the Contact System, Neutrophils and Fibrinogen. In: Liu, C.Y., Chien, S. (eds) Fibrinogen, Thrombosis, Coagulation, and Fibrinolysis. Advances in Experimental Medicine and Biology, vol 281. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3806-6_11
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3806-6_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6697-3
Online ISBN: 978-1-4615-3806-6
eBook Packages: Springer Book Archive